ArticleHeliyon2021
Spatial priority for COVID-19 vaccine rollout against limited supply.
Article in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 13 citations in OpenAlex.
- Article
- Analysis and prediction of infectious diseases based on spatial visualization and machine learning.Scientific reports · 2024Article
- Willingness to accept malaria vaccines amongst women presenting at outpatient and immunization clinics in Enugu state, Southeast Nigeria.Malaria journal · 2024Article
- Article
- Study of optimal vaccination strategies for early COVID-19 pandemic using an age-structured mathematical model: A case study of the USA.Mathematical biosciences and engineering : MBE · 2023Article
- Article
- Article
- More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia.Infection and drug resistance · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 vaccines are limited in supply which requires vaccination by priority. This study proposes a spatial priority-based vaccine rollout strategy for Bangladesh. Demographic, economic and vulnerability, and spatial connectivity - these four types of factors are considered for identifying the spatial priority. The spatial priority is calculated and mapped using a GIS-based analytic hierarchy process. Our findings suggest that both demographic and economic factors are keys to the spatial priority of vaccine rollout. Secondly, spatial connectivity is an essential component for defining spatial priority due to the transmissibility of COVID-19. A total of 12 out of 64 districts were found high-priority followed by 22 medium-priorities for vaccine rollout. The proposed strategy by no means suggests ending mass vaccination by descending age groups but an alternative against limited vaccine supply. The spatial priority of the vaccine rollout strategy proposed in this study might help to curb down COVID-19 transmission and to keep the economy moving. The inclusion of granular data and contextual factors can significantly improve the spatial priority identification which can have wider applications for other infectious and transmittable diseases and beyond.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.